Doug Treco Treco
Vorstandsvorsitzender bei INOZYME PHARMA, INC.
Vermögen: 196 939 $ am 30.04.2024
Profil
Douglas A.
Treco was the founder of Transkaryotic Therapies, Inc. (founded in 1988) where he held the title of Senior Vice President-Research & Development from 1988 to 2005.
He was also the founder of Ra Pharmaceuticals, Inc. (founded in 2008) where he served as President & Chief Executive Officer in 2020.
Currently, Dr. Treco holds the position of Chairman & Chief Executive Officer at Inozyme Pharma, Inc. since 2023.
He is also the Lead Independent Director at CRISPR Therapeutics AG since 2021.
Additionally, he serves as a Scientific Advisor at LSV Capital Management LLC and as a Special Advisor at 3CC Management LLC.
In his former roles, Dr. Treco was the Chief Executive Officer & Director at Alchemab Therapeutics Ltd.
from 2021 to 2022.
He also served as a Director at Xcellerex, Inc. and as an Entrepreneur-in-Residence at Morgenthaler Management Corp.
from 2008 to 2014.
Dr. Treco obtained a doctorate degree from Stony Brook University in 1984 and an undergraduate degree from the University of Delaware in 1979.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CRISPR THERAPEUTICS AG
0,00% | 30.05.2024 | 2 000 ( 0,00% ) | 107 460 $ | 30.04.2024 |
INOZYME PHARMA, INC.
0,03% | 22.04.2024 | 20 665 ( 0,03% ) | 89 479 $ | 30.04.2024 |
Aktive Positionen von Doug Treco Treco
| Unternehmen | Position | Beginn |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direktor/Vorstandsmitglied | 11.06.2020 |
| INOZYME PHARMA, INC. | Vorstandsvorsitzender | 01.04.2023 |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Berater | - |
3CC Management LLC
 3CC Management LLC Investment ManagersFinance 3CC Management LLC (Third Culture Capital) is a venture capital firm founded in 2020 by Julien L. Pham. The firm is headquartered in Boston, Massachusetts. | Berater | - |
Ehemalige bekannte Positionen von Doug Treco Treco
| Unternehmen | Position | Ende |
|---|---|---|
Alchemab Therapeutics Ltd.
 Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Vorstandsvorsitzender | 26.05.2022 |
| RA PHARMACEUTICALS, INC. | Gründer | 01.07.2020 |
Morgenthaler Management Corp.
 Morgenthaler Management Corp. Investment ManagersFinance Morgenthaler Management Corp (Morgenthaler Management) is a venture capital and private equity firm founded in 1968 by David Morgenthaler. The firm is headquartered in Portola Valley, California. | Private Equity Investor | 31.01.2014 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Gründer | 01.01.2005 |
Xcellerex, Inc.
 Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Doug Treco Treco
| University of Delaware | Undergraduate Degree |
| Stony Brook University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Xcellerex, Inc.
Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Health Technology |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Morgenthaler Management Corp.
Morgenthaler Management Corp. Investment ManagersFinance Morgenthaler Management Corp (Morgenthaler Management) is a venture capital and private equity firm founded in 1968 by David Morgenthaler. The firm is headquartered in Portola Valley, California. | Finance |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Finance |
Alchemab Therapeutics Ltd.
Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Health Technology |
3CC Management LLC
3CC Management LLC Investment ManagersFinance 3CC Management LLC (Third Culture Capital) is a venture capital firm founded in 2020 by Julien L. Pham. The firm is headquartered in Boston, Massachusetts. | Finance |
